calcimycin and Xeroderma-Pigmentosum

calcimycin has been researched along with Xeroderma-Pigmentosum* in 1 studies

Other Studies

1 other study(ies) available for calcimycin and Xeroderma-Pigmentosum

ArticleYear
Ca(2+)-mediated inhibition of a nuclear protein that recognizes UV-damaged DNA and is constitutively overexpressed in resistant human cells: DNA-binding assay.
    Nucleic acids research, 1991, Dec-11, Volume: 19, Issue:23

    A nuclear protein that recognizes UV-damaged DNA was detected from HeLa cells using DNA-binding assay. Treatment of cells with Ca2+ ionophore (A23187) caused a dramatic inhibition of the damage-recognition activity. In contrast, in vitro treatment of nuclear extracts with agents that affect protein conformation (such as urea, NP40 and Ca2+) did not significantly affect on the damage-recognition activity. The Ca(2+)-mediated inhibition of UV damage recognition was reconstituted by the addition of the cytosolic extracts, suggesting that the Ca2+ effect does not directly act on the UV damage-recognition protein. The expression of the detected nuclear protein was increased in UV-resistant HeLa cells. In contrast, the level of this protein was dramatically reduced in UV-sensitive xeroderma pigmentosum group A cells. In addition, UV damage-recognition protein is resistant to RNase, and is independent of the previously identified proteins that bind cisplatin-DNA adduct. These findings implied that the recognition of UV-DNA adduct is modulated by the intracellular level of Ca2+.

    Topics: Binding, Competitive; Calcimycin; Calcium; Cell Survival; Cisplatin; DNA; DNA Damage; DNA-Binding Proteins; Drug Resistance; Gene Expression Regulation; HeLa Cells; Humans; Nuclear Proteins; Protein Conformation; Tumor Cells, Cultured; Ultraviolet Rays; Xeroderma Pigmentosum

1991